XML 18 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Income Statement [Abstract]      
Revenues $ 143,167 $ 59,775
Research and development expenses (Note 11) 2,268,345 1,849,624 $ 1,986,754
Selling, marketing and general and administrative expenses (Note 12) 2,530,175 1,817,510 1,041,140
Total operating expenses 4,798,520 3,667,134 3,027,894
Operating loss 4,655,353 3,607,359 3,027,894
Financing (income) expenses, net (Note 13) 1,186,819 (6,587,785) 6,768,959
Income (loss) for the period (5,842,172) 2,980,426 (9,796,853)
Other comprehensive income (loss):      
Foreign currency translation adjustment 23,498 13,968 43,777
Comprehensive income (loss) for the period $ (5,818,674) $ 2,994,394 $ (9,753,076)
Income (loss) per share (Basic) (Note 15) $ (1.15) $ 0.37 $ (1.95)
Income (loss) per share (Diluted) (Note 15) $ (1.15) $ 0.37 $ (1.95)
Common shares used in computing Basic income (loss) per share (Note 15) 5,476,870 5,304,500 5,325,714
Common shares used in computing Diluted income (loss) per share (Note 15) [1] 5,476,870 5,349,242 5,325,714
[1] In applying the treasury method, the average market price of Common Stock was based on management estimate. For December 31, 2015 and 2014, management estimation considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series B Units (See Note 10C). The fair value per share of the Company's Common Stock as of December 31, 2013 was based on the management's estimate which was based among other factors on the closing price per share of the Company's Common Stock on December 27, 2013, as reported on the OTCQB, which was the last reported sale of Common Stock in 2013.